Cargando…
Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
BACKGROUND: Antidepressants have been proposed to act via their influence on emotional processing. We investigated the effect of discontinuing maintenance antidepressant treatment on positive and negative self-referential recall and the association between self-referential recall and risk of relapse...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600933/ https://www.ncbi.nlm.nih.gov/pubmed/36727498 http://dx.doi.org/10.1017/S0033291722003981 |
_version_ | 1785126092206505984 |
---|---|
author | Rodriguez-Sanchez, Julia Lewis, Gemma Solmi, Francesca Bone, Jessica K. Moore, Michael Wiles, Nicola Harmer, Catherine J. Duffy, Larisa Lewis, Glyn |
author_facet | Rodriguez-Sanchez, Julia Lewis, Gemma Solmi, Francesca Bone, Jessica K. Moore, Michael Wiles, Nicola Harmer, Catherine J. Duffy, Larisa Lewis, Glyn |
author_sort | Rodriguez-Sanchez, Julia |
collection | PubMed |
description | BACKGROUND: Antidepressants have been proposed to act via their influence on emotional processing. We investigated the effect of discontinuing maintenance antidepressant treatment on positive and negative self-referential recall and the association between self-referential recall and risk of relapse. METHODS: The ANTLER trial was a large (N = 478) pragmatic double-blind trial investigating the clinical effectiveness of long-term antidepressant treatment for preventing relapse in primary care patients. Participants were randomised to continue their maintenance antidepressants or discontinue via a taper to placebo. We analysed memory for positive and negative personality descriptors, assessed at baseline, 12- and 52-week follow-up. RESULTS: The recall task was completed by 437 participants. There was no evidence of an effect of discontinuation on self-referential recall at 12 [positive recall ratio 1.00, 95% CI (0.90–1.11), p = 0.93; negative recall ratio 1.00 (0.87–1.14), p = 0.87] or 52 weeks [positive recall ratio 1.03 (0.91–1.17), p = 0.62; negative recall ratio 1.00 (0.86–1.15), p = 0.96; ratios larger than one indicate higher recall in the discontinuation group], and no evidence of an association between recall at baseline or 12 weeks and later relapse [baseline, positive hazard ratio (HR) 1.02 (0.93–1.12), p = 0.74; negative HR 1.01 (0.90–1.13), p = 0.87; 12 weeks, positive HR 0.99 (0.89–1.09), p = 0.81; negative HR 0.98 (0.84–1.14), p = 0.78; ratios larger than one indicate a higher frequency of relapse in those with higher recall]. CONCLUSIONS: We found no evidence that discontinuing long-term antidepressants altered self-referential recall or that self-referential recall was associated with risk of relapse. These findings suggest that self-referential recall is not a neuropsychological marker of antidepressant action. |
format | Online Article Text |
id | pubmed-10600933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106009332023-10-27 Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial Rodriguez-Sanchez, Julia Lewis, Gemma Solmi, Francesca Bone, Jessica K. Moore, Michael Wiles, Nicola Harmer, Catherine J. Duffy, Larisa Lewis, Glyn Psychol Med Original Article BACKGROUND: Antidepressants have been proposed to act via their influence on emotional processing. We investigated the effect of discontinuing maintenance antidepressant treatment on positive and negative self-referential recall and the association between self-referential recall and risk of relapse. METHODS: The ANTLER trial was a large (N = 478) pragmatic double-blind trial investigating the clinical effectiveness of long-term antidepressant treatment for preventing relapse in primary care patients. Participants were randomised to continue their maintenance antidepressants or discontinue via a taper to placebo. We analysed memory for positive and negative personality descriptors, assessed at baseline, 12- and 52-week follow-up. RESULTS: The recall task was completed by 437 participants. There was no evidence of an effect of discontinuation on self-referential recall at 12 [positive recall ratio 1.00, 95% CI (0.90–1.11), p = 0.93; negative recall ratio 1.00 (0.87–1.14), p = 0.87] or 52 weeks [positive recall ratio 1.03 (0.91–1.17), p = 0.62; negative recall ratio 1.00 (0.86–1.15), p = 0.96; ratios larger than one indicate higher recall in the discontinuation group], and no evidence of an association between recall at baseline or 12 weeks and later relapse [baseline, positive hazard ratio (HR) 1.02 (0.93–1.12), p = 0.74; negative HR 1.01 (0.90–1.13), p = 0.87; 12 weeks, positive HR 0.99 (0.89–1.09), p = 0.81; negative HR 0.98 (0.84–1.14), p = 0.78; ratios larger than one indicate a higher frequency of relapse in those with higher recall]. CONCLUSIONS: We found no evidence that discontinuing long-term antidepressants altered self-referential recall or that self-referential recall was associated with risk of relapse. These findings suggest that self-referential recall is not a neuropsychological marker of antidepressant action. Cambridge University Press 2023-10 2023-02-02 /pmc/articles/PMC10600933/ /pubmed/36727498 http://dx.doi.org/10.1017/S0033291722003981 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article Rodriguez-Sanchez, Julia Lewis, Gemma Solmi, Francesca Bone, Jessica K. Moore, Michael Wiles, Nicola Harmer, Catherine J. Duffy, Larisa Lewis, Glyn Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial |
title | Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial |
title_full | Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial |
title_fullStr | Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial |
title_full_unstemmed | Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial |
title_short | Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial |
title_sort | neuropsychological markers of antidepressant action: a secondary analysis of the antler randomised controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600933/ https://www.ncbi.nlm.nih.gov/pubmed/36727498 http://dx.doi.org/10.1017/S0033291722003981 |
work_keys_str_mv | AT rodriguezsanchezjulia neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT lewisgemma neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT solmifrancesca neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT bonejessicak neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT mooremichael neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT wilesnicola neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT harmercatherinej neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT duffylarisa neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial AT lewisglyn neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial |